Doctor Evidence, LLC (“DRE”) Expands Medical Strategy Advisory Board to Strengthen its Artificial Intelligence Solution in Drug Discovery
SANTA MONICA, Calif.--(BUSINESS WIRE)--DRE is pleased to welcome four new members to its MSAB. They join Chair, Ameet Nathwani, MD, MRCP, DipPharmMed, MBA in advising DRE on the convergence of expert AI-enabled technology in healthcare and the exponential growth of clinical information. DRE offers software solutions that enable researchers, scientists and physicians to rapidly discover and analyze data from vast and varied medical information including clinical studies, real world data, and pre
